Close Menu
Home › Diagnostics › Drug Discovery & Development

Drug Discovery & Development

News on drug screening, clinical trials, companion diagnostics, immunotherapy, & personalized therapies in genetics, genomics, and molecular diagnostics.

CHMP Issues Positive Decision for Keytruda in First Line PD-L1 Positive Head, Neck Cancer

Premium

The European Commission will review CHMP's recommendation and is slated to issue a final decision regarding marketing authorization later this year.

Phase III Trial Suggests Tecentriq Survival Benefit in Bladder Cancer Subgroup

IMvigor130 data suggests atezolizumab plus chemotherapy delays progression in urothelial carcinoma, with potential survival benefit seen in PD-L1 subgroup treated with monotherapy.

 

ESMO 2019 Precision Oncology Highlights

A collection of biomarker- and genomic testing-driven precision oncology research presented at the European Society of Medical Oncology Congress. 


Trial Data Reveals Progression Delay in Cholangiocarcinoma with Targeted IDH1 Drug

Based on the strength of the data from the ClarIDHy trial, Agios Pharmaceuticals is aiming to submit for regulatory approval with the FDA by year end.  

Roche's Tecentriq Demonstrates Survival Benefit in PD-L1 High NSCLC

The drugmaker will present data from the Impower110 trial at an upcoming meeting and submit the data to regulatory authorities.

Sep 10, 2019

Repare Therapeutics Using CRISPR to Develop Cancer Treatments for Synthetic Lethal Targets

Premium
Sep 10, 2019

Keytruda Plus Chemotherapy Extends Survival in NSCLC Patients Lacking PD-L1 Expression

Sep 10, 2019

SEngine Precision Medicine, Atomwise Partner on Personalized Cancer Drug Development

Sep 09, 2019

Eli Lilly's Selpercatinib Shows Strong Activity in RET Fusion-Positive NSCLC

Sep 05, 2019

Bristol-Myers Squibb to Continue Phase III Opdivo Study in Glioblastoma Despite PFS Setback

Sep 03, 2019

Kura Oncology Sees Proof of Tipifarnib Activity in HRAS-Mutated Urothelial Cancer

Aug 26, 2019

Trovagene Sees Signs of Efficacy for Onvansertib in AR-V7 Castration-Resistant Prostate Cancer

Aug 16, 2019

Xylonix, BioGemex Ink MOU to Develop Point-of-Care Cancer Immunotherapy-Response Diagnostic

Aug 15, 2019

GeneCentric Therapeutics to Launch Phase II Validation Study for Head and Neck Cancer Subtyper

Premium
Aug 06, 2019

Lung Cancer Survival Benefit From Gilotrif, Tagrisso Sequence Therapy Emerges from Real-World Data

Aug 06, 2019

Sophia Genetics Teams With ADC Therapeutics on Biomarker Discovery for Lymphoma Treatment

Aug 01, 2019

Novartis Launches Free BRAF Testing Program Hoping to Close Access Gaps, Maintain Market Lead

Premium
Jul 29, 2019

NEC Acquires Bioinformatics Firm OncoImmunity

Jul 26, 2019

UK's NICE Issues Positive Draft Guidance for AstraZeneca's Lynparza in BRCA-Positive Ovarian Cancer

Jul 26, 2019

European Commission Recommends Approval of Tecentriq-Chemo Combo in First-Line Metastatic NSCLC

Jul 24, 2019

Gray Foundation Awards $25M in Cancer Research Grants

Jul 18, 2019

Elios Therapeutics Phase IIb Personalized Vaccine Study Yields Positive Top-Line Results

Jul 17, 2019

Cancer Drug Discovery Firm Notable Nabs $40M in Series B Funding Round

Jul 09, 2019

Trovagene Starts Onvansertib Trial in KRAS-Mutated Colorectal Cancer

Jul 03, 2019

Japan, China Launch Basket, Umbrella Trials to Expand Precision Oncology Treatment Access

Premium
More articles
Oct
23
Featured Webinar

Single-Cell Methylation Profiling of Pediatric Tumors via a Unique NGS-based Approach

This webinar will illustrate how single-cell methylation sequencing can be applied to gain significant insight into epigenetic heterogeneity in disease states, advancing cancer research discoveries. 

What's Popular?

In Drug Discovery & Development

  1. CHMP Issues Positive Decision for Keytruda in First Line PD-L1 Positive Head, Neck Cancer

    Premium

Sponsorships

Privacy Policy.  Terms & Conditions.  Copyright © 2019 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.